Variant report
Variant | esv2137795 |
---|---|
Chromosome Location | chr5:124484183-124484620 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10071085 | chr5:124484200-124484201 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs571020208 | chr5:124484206-124484207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541820304 | chr5:124484210-124484211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556277737 | chr5:124484223-124484224 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12189383 | chr5:124484247-124484248 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs144737659 | chr5:124484267-124484268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs111827543 | chr5:124484268-124484269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13167433 | chr5:124484297-124484298 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs13187207 | chr5:124484307-124484308 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs557698690 | chr5:124484362-124484363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200145535 | chr5:124484390-124484391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200868706 | chr5:124484391-124484392 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201697470 | chr5:124484392-124484393 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200084502 | chr5:124484395-124484396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs201215182 | chr5:124484396-124484397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575819194 | chr5:124484460-124484461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543181424 | chr5:124484476-124484477 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78569309 | chr5:124484481-124484482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530087130 | chr5:124484493-124484494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541865122 | chr5:124484530-124484531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs115429033 | chr5:124484536-124484537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528021281 | chr5:124484547-124484548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76300686 | chr5:124484561-124484562 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12520570 | chr5:124484570-124484571 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs369694953 | chr5:124484608-124484609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 16397240 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:124471400-124484600 | Weak transcription | HSMM | muscle |
2 | chr5:124477200-124488200 | Weak transcription | HUVEC | blood vessel |
3 | chr5:124477400-124484600 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr5:124478800-124484200 | Weak transcription | NHDF-Ad | bronchial |
5 | chr5:124483000-124484600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr5:124484000-124490800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr5:124484200-124485400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr5:124484200-124485400 | Enhancers | NHDF-Ad | bronchial |
9 | chr5:124484200-124486400 | Enhancers | Fetal Stomach | stomach |
10 | chr5:124484400-124484800 | Enhancers | HSMMtube | muscle |
11 | chr5:124484400-124486000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr5:124484600-124484800 | Enhancers | Adipose Nuclei | Adipose |
13 | chr5:124484600-124485000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr5:124484600-124485200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
15 | chr5:124484600-124485200 | Enhancers | HSMM | muscle |